Compositions with and process for methylmorpholin-substituted pyrido [2,3-D] pyrimidines

Details for Australian Patent Application No. 2009261688 (hide)

International Classifications

Event Publications

27 January 2011 PCT application entered the National Phase

PCT publication WO2009/153597 Priority application(s): WO2009/153597

17 March 2011 Amendment Made

The nature of the amendment is: Amend the invention title to read Compositions with and process for methylmorpholin-subsituted pyrido [2,3-D] pyrimidines

12 May 2011 Corrigenda

Amendments - Amendments Made Under the name AstraZeneca AB, application No. 2009261688, under INID (54) correct the title to Compositions with and process for methylmorpholin-substituted pyrido [2,3-D] pyrimidines

5 July 2012 Application Accepted

Published as AU-B-2009261688

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.